Integrating Proteomics and Mendelian Randomization to Identify New Therapeutic Targets.
作者信息
Santulli Gaetano, Varzideh Fahimeh, Kansakar Urna, Jankauskas Stanislovas S, Wilson Scott, Mone Pasquale
机构信息
Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Einstein - Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Neuroimmunology and Inflammation (INI), Albert Einstein College of Medicine, New York, NY, USA.
Department of Molecular Pharmacology, Einstein Institute for Aging Research, Fleischer Institute for Diabetes and Metabolism (FIDAM), Albert Einstein College of Medicine, New York, NY, USA.
出版信息
Am J Hypertens. 2025 Mar 14. doi: 10.1093/ajh/hpaf034.
Abstract
摘要
相似文献
1
Integrating Proteomics and Mendelian Randomization to Identify New Therapeutic Targets.整合蛋白质组学与孟德尔随机化以识别新的治疗靶点。
Am J Hypertens. 2025 Mar 14. doi: 10.1093/ajh/hpaf034.
2
Identification of therapeutic targets for psoriatic arthritis through proteomics.通过蛋白质组学鉴定银屑病关节炎的治疗靶点
Clin Rheumatol. 2025 May 29. doi: 10.1007/s10067-025-07508-7.
3
Exploring causal plasma protein level ratios and potential drug targets for depression: A proteomics Mendelian randomization study.探索抑郁症的因果血浆蛋白水平比值及潜在药物靶点：一项蛋白质组学孟德尔随机化研究
J Affect Disord. 2025 Nov 15;389:119647. doi: 10.1016/j.jad.2025.119647. Epub 2025 Jun 9.
4
Identification of Proteomic Biomarkers and Therapeutic Targets for Vitiligo Using a Two-Sample Proteome-Wide Mendelian Randomization Approach.使用双样本蛋白质组全基因组孟德尔随机化方法鉴定白癜风的蛋白质组学生物标志物和治疗靶点。
J Cosmet Dermatol. 2025 Sep;24(9):e70420. doi: 10.1111/jocd.70420.
5
Revealing potential drug targets in liver dysfunction through proteome-wide Mendelian randomization.通过全蛋白质组孟德尔随机化揭示肝功能障碍中的潜在药物靶点。
Medicine (Baltimore). 2025 Sep 12;104(37):e44628. doi: 10.1097/MD.0000000000044628.
6
Interconnections between BDH1-plasma protein-type 2 diabetes Mellitus: a mediated mendelian randomization analysis using plasma proteomics.BDH1与血浆蛋白型2型糖尿病之间的关联：一项使用血浆蛋白质组学的中介孟德尔随机化分析
Sci Rep. 2025 Jan 27;15(1):3342. doi: 10.1038/s41598-025-88196-w.
7
Systematic Druggable-Proteome-Wide Mendelian Randomization Identifies Potential Therapeutic Targets for Allergic Conjunctivitis.全蛋白质组范围的系统性孟德尔随机化研究确定了过敏性结膜炎的潜在治疗靶点。
Transl Vis Sci Technol. 2025 Jul 1;14(7):6. doi: 10.1167/tvst.14.7.6.
8
Therapeutic targets for Alzheimer's disease: Proteome-wide Mendelian randomization and colocalization analyses.阿尔茨海默病的治疗靶点：全蛋白质组孟德尔随机化和共定位分析
J Alzheimers Dis. 2025 Jun 2:13872877251344572. doi: 10.1177/13872877251344572.
9
Identification of Therapeutic Targets for Premature Ovarian Failure Through Mendelian Randomization and Colocalization Analysis Using Human Plasma Proteomics.通过孟德尔随机化和使用人类血浆蛋白质组学的共定位分析确定卵巢早衰的治疗靶点
J Mol Neurosci. 2025 Aug 30;75(3):111. doi: 10.1007/s12031-025-02314-x.
10
Exploring potential therapeutic targets for cardiomyopathy: A proteome-wide Mendelian randomization analysis.探索心肌病的潜在治疗靶点：一项全蛋白质组孟德尔随机化分析。
Medicine (Baltimore). 2025 Jun 13;104(24):e42681. doi: 10.1097/MD.0000000000042681.
本文引用的文献
1
Mid-life physical activity and calcification of coronary arteries, aorta, and cardiac valves in late life: The Atherosclerosis Risk in Communities (ARIC) study.中年时期的身体活动与晚年冠状动脉、主动脉及心脏瓣膜钙化：社区动脉粥样硬化风险（ARIC）研究
Atherosclerosis. 2025 Mar;402:119115. doi: 10.1016/j.atherosclerosis.2025.119115. Epub 2025 Jan 29.
2
Potential Therapeutic Drug Targets for Hypertension Identified Using Proteomics and Mendelian Randomization.利用蛋白质组学和孟德尔随机化确定的高血压潜在治疗药物靶点
Am J Hypertens. 2025 Sep 16;38(10):841-851. doi: 10.1093/ajh/hpaf011.
3
Recent advancements in targeting the immune system to treat hypertension.靶向免疫系统治疗高血压的最新进展。
Eur J Pharmacol. 2024 Nov 15;983:177008. doi: 10.1016/j.ejphar.2024.177008. Epub 2024 Sep 18.
4
Advances in Understanding of the Role of Immune Cell Phenotypes in Hypertension and Associated Vascular Disease.免疫细胞表型在高血压及相关血管疾病中的作用的认识进展
Can J Cardiol. 2024 Dec;40(12):2321-2339. doi: 10.1016/j.cjca.2024.08.270. Epub 2024 Aug 21.
5
Genome-wide association studies highlight novel risk loci for septal defects and left-sided congenital heart defects.全基因组关联研究强调了隔膜缺陷和左侧先天性心脏缺陷的新风险位点。
BMC Genomics. 2024 Mar 7;25(1):256. doi: 10.1186/s12864-024-10172-x.
6
Mitochondria in endothelial cells angiogenesis and function: current understanding and future perspectives.内皮细胞血管生成和功能中的线粒体：当前的认识和未来展望。
J Transl Med. 2023 Jul 5;21(1):441. doi: 10.1186/s12967-023-04286-1.
7
The therapeutic concordance approach reduces adverse drug reactions in patients with resistant hypertension.治疗一致性方法可减少顽固性高血压患者的药物不良反应。
Front Cardiovasc Med. 2023 May 5;10:1137706. doi: 10.3389/fcvm.2023.1137706. eCollection 2023.
8
Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets.炎症、免疫和氧化应激在高血压中的作用：新的见解和潜在的治疗靶点。
Front Immunol. 2023 Jan 10;13:1098725. doi: 10.3389/fimmu.2022.1098725. eCollection 2022.
9
The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.选择性醛固酮合酶抑制剂巴多司他可显著降低顽固性高血压患者的血压。
Front Endocrinol (Lausanne). 2022 Dec 9;13:1097968. doi: 10.3389/fendo.2022.1097968. eCollection 2022.
10
The emerging multifunctional roles of ERAP1, ERAP2 and IRAP between antigen processing and renin-angiotensin system modulation.内质网氨肽酶 1（ERAP1）、内质网氨肽酶 2（ERAP2）和免疫相关氨肽酶（IRAP）在抗原加工和肾素-血管紧张素系统调节之间新兴的多功能作用。
Front Immunol. 2022 Sep 20;13:1002375. doi: 10.3389/fimmu.2022.1002375. eCollection 2022.
Zotero 插件